ATA15392001A - Humanes endogenes retrovirus - Google Patents

Humanes endogenes retrovirus

Info

Publication number
ATA15392001A
ATA15392001A AT0153901A AT15392001A ATA15392001A AT A15392001 A ATA15392001 A AT A15392001A AT 0153901 A AT0153901 A AT 0153901A AT 15392001 A AT15392001 A AT 15392001A AT A15392001 A ATA15392001 A AT A15392001A
Authority
AT
Austria
Prior art keywords
endogenic
retrovirus
human
human endogenic
endogenic retrovirus
Prior art date
Application number
AT0153901A
Other languages
English (en)
Other versions
AT411262B (de
Original Assignee
Wolff Klaus Dr
Muster Thomas Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wolff Klaus Dr, Muster Thomas Dr filed Critical Wolff Klaus Dr
Priority to AT0153901A priority Critical patent/AT411262B/de
Priority to PCT/EP2002/010899 priority patent/WO2003029460A1/en
Priority to US10/490,920 priority patent/US7510862B2/en
Priority to EP02779436A priority patent/EP1430127A1/de
Publication of ATA15392001A publication Critical patent/ATA15392001A/de
Application granted granted Critical
Publication of AT411262B publication Critical patent/AT411262B/de
Priority to US11/828,272 priority patent/US20080008717A1/en
Priority to US12/261,374 priority patent/US8008460B2/en
Priority to US13/451,256 priority patent/US20120237527A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/5743—Specifically defined cancers of skin, e.g. melanoma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
AT0153901A 2001-09-27 2001-09-27 Humanes endogenes retrovirus AT411262B (de)

Priority Applications (7)

Application Number Priority Date Filing Date Title
AT0153901A AT411262B (de) 2001-09-27 2001-09-27 Humanes endogenes retrovirus
PCT/EP2002/010899 WO2003029460A1 (en) 2001-09-27 2002-09-27 Polynucleotide fragments of an infectious human endogenous retrovirus
US10/490,920 US7510862B2 (en) 2001-09-27 2002-09-27 Polynucleotide fragments of an infectious human endogenous retrovirus
EP02779436A EP1430127A1 (de) 2001-09-27 2002-09-27 Polynukleotidfragmente aus einem infektiösen menschlichen endogenen retrovirus
US11/828,272 US20080008717A1 (en) 2001-09-27 2007-07-25 Polynucleotide Fragments of an Infectious Human Endogenous Retrovirus
US12/261,374 US8008460B2 (en) 2001-09-27 2008-10-30 Polynucleotide fragments of an infectious human endogenous retrovirus
US13/451,256 US20120237527A1 (en) 2001-09-27 2012-04-19 Polynucleotide Fragments of an Infectious Human Endogenous Retrovirus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0153901A AT411262B (de) 2001-09-27 2001-09-27 Humanes endogenes retrovirus

Publications (2)

Publication Number Publication Date
ATA15392001A true ATA15392001A (de) 2003-04-15
AT411262B AT411262B (de) 2003-11-25

Family

ID=3688328

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0153901A AT411262B (de) 2001-09-27 2001-09-27 Humanes endogenes retrovirus

Country Status (4)

Country Link
US (4) US7510862B2 (de)
EP (1) EP1430127A1 (de)
AT (1) AT411262B (de)
WO (1) WO2003029460A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT411262B (de) * 2001-09-27 2003-11-25 Wolff Klaus Dr Humanes endogenes retrovirus
ES2339433T3 (es) * 2001-12-07 2010-05-20 Novartis Vaccines And Diagnostics, Inc. Aumento de la expresion de retrovirus endogeno en cancer de prostata.
US7858743B2 (en) * 2004-09-09 2010-12-28 Ludwig Institute For Cancer Research SSX-4 peptides presented by HLA class II molecules
DK1871391T3 (da) * 2005-03-30 2012-04-16 Viroxis Endogen retrovirus og proteiner, der kodes af env som target for cancerbehandling
AT502292B1 (de) * 2005-05-11 2010-04-15 Avir Green Hills Biotechnology Melanomdiagnose
US20090297530A1 (en) * 2006-05-22 2009-12-03 Feng Wang-Johanning Herv-k antigens, antibodies, and methods
US20080171061A1 (en) * 2006-07-21 2008-07-17 Douglas Nixon Human endogenous retrovirus polypeptide compositions and methods of use thereof
AT505028B1 (de) * 2008-02-01 2008-10-15 Avir Green Hills Biotechnology Neuer antikörper gegen ein retrovirales epitop
EP2160406B1 (de) * 2007-05-24 2013-10-02 Baxter Healthcare SA Zur therapie und diagnose von krebs geeignete antikörper

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4769234A (en) * 1987-10-06 1988-09-06 Peter M. Stephan Center Ltd. Skin care compositions containing polyvalent equine immune serum
JP2885689B2 (ja) * 1996-03-26 1999-04-26 有限会社エムティーアンドエル医学研究所 ヒト内在性レトロウイルス遺伝子由来のポリペプチドまたは該ポリペプチドに対する抗体からなる癌検出剤
AU7622998A (en) * 1996-12-02 1998-06-29 Georgetown University Human trophoblast and choriocarcinoma inhibition
US6396549B1 (en) 1997-11-19 2002-05-28 Harold J. Weber Remote controller for a multi-device television receiving system providing channel number auto-completion, presettable audio hush level and base channel auto-reaffirm
DE19811692A1 (de) * 1998-03-18 1999-09-23 Merck Patent Gmbh Sonnenschutzformulierungen mit Wirkung gegen Herpes Simplex Viren
FR2780069B1 (fr) * 1998-06-23 2002-06-28 Inst Nat Sante Rech Med Famille de sequences nucleiques et de sequences proteiques deduites presentant des motifs retroviraux endogenes humains et leurs applications
US6770456B1 (en) * 1998-07-29 2004-08-03 Ludwig Institute For Cancer Research Endogenous retrovirus tumor associated nucleic acids and antigens
WO2000020460A1 (en) * 1998-10-05 2000-04-13 Ludwig Institute For Cancer Research Methods for producing human tumor antigen specific antibodies
WO2000023606A1 (en) * 1998-10-22 2000-04-27 Medical College Of Georgia Institute, Inc. Long terminal repeat, enhancer, and insulator sequences for use in recombinant vectors
DE19910650A1 (de) * 1999-03-10 2000-09-21 Gsf Forschungszentrum Umwelt Auf HERV-LTR-Sequenzen basierende retrovirale Expressionsvektoren
CA2393859A1 (en) * 1999-12-10 2001-06-14 Leadd B.V. Apoptin-associating protein
FR2805279B1 (fr) * 2000-02-23 2004-09-24 Jean Jacques Guilhou Sequences retrovirales associees a des affections cutanees
IL151868A0 (en) * 2000-03-21 2003-04-10 Ms Res As An infective endogenous retrovirus and its association with demyelinating diseases and other diseases
WO2002046477A2 (en) * 2000-12-07 2002-06-13 Chiron Corporation Endogenous retroviruses up-regulated in prostate cancer
AT411262B (de) * 2001-09-27 2003-11-25 Wolff Klaus Dr Humanes endogenes retrovirus

Also Published As

Publication number Publication date
US20040241642A1 (en) 2004-12-02
WO2003029460A1 (en) 2003-04-10
US7510862B2 (en) 2009-03-31
EP1430127A1 (de) 2004-06-23
US20080008717A1 (en) 2008-01-10
US8008460B2 (en) 2011-08-30
US20090180975A1 (en) 2009-07-16
US20120237527A1 (en) 2012-09-20
AT411262B (de) 2003-11-25

Similar Documents

Publication Publication Date Title
DE60222056D1 (de) Hebestuhl
FI20010694A (fi) Implantti
DE60208982D1 (de) Fussbad
DE10158785B8 (de) Medizinisches Implantat
DE60214314D1 (de) Optometrisches Instrument
DE50209245D1 (de) Neuroprotektives medikament
DE60225985D1 (de) Dentaleinheit
DE60210848D1 (de) Verbinder
ATA15392001A (de) Humanes endogenes retrovirus
PT1430313E (pt) Transformador de medicao
DE50203644D1 (de) Abseilvorrichtung
DE60114244D1 (de) Osteosynthesevorrichtung
DE60221366D1 (de) Verbinder
DE60233695D1 (de) Verbinder
FR2825911B1 (fr) Implant cotyloidien
DE50108179D1 (de) Verbinder
DE60237655D1 (de) Entwicklungsgerät
DE50201746D1 (de) Prothese
DE60228736D1 (de) Menschliches bmcc1-gen
DE60229395D1 (de) Altung
NO20012945D0 (no) Fat
DE50200043D1 (de) Steighilfe
DE60221724D1 (de) Anti-HIV Substanz
DE60201822D1 (de) Sterilisierverfahren
NO20015559D0 (no) Kreklinggel±

Legal Events

Date Code Title Description
PC Change of the owner

Owner name: BAXTER HEALTHCARE SA, CH

Effective date: 20140307

MM01 Lapse because of not paying annual fees

Effective date: 20140415